Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia.
Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Apr 19; 81(8):594-602.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Agranulocytosis
Blood Transfusion
Cost-Benefit Analysis
Female
Hemoglobins
Humans
Interferon Type I
Interferon-alpha
Leukemia, Hairy Cell
Male
Middle Aged
Neoplasm Staging
Prognosis
Recombinant Proteins
Retrospective Studies
authors with profiles
Harvey M. Golomb